Implementing Measurement-Based Care to Determine and Treat Inadequate Response

Madhukar H. Trivedi, George I. Papakostas, W. Clay Jackson, Roueen Rafeyan

Research output: Contribution to journalArticle

Abstract

​​ Measurement-based care (MBC) is an important strategy in the treatment of patients with major depressive disorder who have inadequate antidepressant response. The rating scales used in MBC can assist clinicians at critical decision points, such as when to declare a treatment failure, what to do with partial improvement, and how long to continue successful treatment. Measurement has two benefits: it gives the clinician an objective basis for comparison of symptom severity over time, and it helps patients to have insight into their illness course. Further, many of these tools do not add substantially to the length of the clinical visit. MBC can also be used to monitor and address residual symptoms such as fatigue and irritability that impact patients' functioning and quality of life.​ ​.

Original languageEnglish (US)
JournalThe Journal of clinical psychiatry
Issue number3
DOIs
StatePublished - May 5 2020

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Implementing Measurement-Based Care to Determine and Treat Inadequate Response'. Together they form a unique fingerprint.

  • Cite this